Perinatal mental health challenges rarely appear overnight. They begin quietly—leaving subtle signals in the body long before they are recognized as problems. Too often, those signals are missed.
The founder, Frayer, first realized this not in a lab, but during the pandemic. In an environment defined by prolonged stress and uncertainty, he saw people who were never diagnosed as “ill” begin to experience persistent insomnia, heart palpitations, and chronic fatigue. Emotional strain did not remain psychological—it manifested physically, gradually and unmistakably.
That was when it became clear:
mental and physical health are not separate pathways.
They interact, reinforce one another, and evolve together—forming a psychophysiological feedback loop. Over time, Frayer would encounter this same pattern again and again—in healthcare systems, in product data, and in his own life.
The decision to focus on perinatal mental health (PMADs) was not driven by trends. It was driven by impact. Globally, 1 in 5 pregnancies is affected by PMADs. Yet among those cases, 57.68% are never diagnosed, and 85.07% receive no treatment. This is not just a mental health issue. Each untreated case results in an estimated USD 35,500 in combined maternal–fetal cost, with 60% affecting mothers and 40% impacting fetal and neonatal outcomes, often extending for years.
This issue once unfolded very close to home. Frayer’s sister is an anesthesiologist at a top-tier hospital. She understood medicine, followed protocols, and completed approximately 14 routine prenatal visits during pregnancy. Yet among those visits, only one included a PMADs-related screening, entirely based on self-reported questionnaires.
In a system shaped by stigma, limited awareness, and insufficient attention from both healthcare and family, she did not disclose the full extent of her distress. She was living under sustained clinical overtime and chronic psychological stress—neither of which disappeared. Over time, those pressures accumulated through sleep disruption, behavioral changes, and physiological dysregulation.
She experienced preterm birth.
Her twin daughters spent months in neonatal care, remaining physically fragile. She herself developed severe postpartum depression and has been unable to return to her previous work and life. Nothing happened suddenly. The signals were there—but they were missed.
This is not an isolated story. It reflects a structural gap. Despite an average of 14 prenatal visits, PMADs screening typically occurs only once, relying heavily on subjective self-report. Meanwhile, PMADs evolve continuously, quietly, and in everyday life. If risk is assessed only at a few isolated moments, it is impossible to understand how it forms.
This is why the team starts with the psychophysiological feedback loop. PMADs are not single events. They emerge through prolonged psychological stress, reinforced by behavior and physiology, eventually manifesting as both mental and physical risk. Effective intervention must happen where life happens—continuously.
Rather than traditional medical devices, Frayer and his team chose wearable jewelry. As medical devices become consumer electronics—and consumer electronics become jewelry—discreet, non-clinical form factors reduce stigma and integrate naturally into daily life. Among wearables, rings achieve over 80% adherence among perinatal women, particularly at night.
Nighttime physiological data is among the most stable and critical signals for PMADs modeling. Through industrial design, the team addressed finger-size changes caused by edema and weight fluctuation, preventing the sharp adherence drop often seen in late pregnancy and postpartum.
Clinical evidence shows that high-adherence behavioral interventions can reduce PMADs incidence by 80–90%. The challenge is not efficacy, but personalization and sustainability. AI agents enable continuous understanding, adaptive interventions, and actionable daily guidance—without adding burden.
Even in the United States, approximately 46% of pregnant women rely on Medicaid, making long-term human health coaching inaccessible. If AI can deliver 80% of human-level capability, it can provide 70–80% quality support at scale, while enabling AI-plus-human care for those who seek premium services.
This is not a short-term initiative. It is an effort to repair a system where early signals have gone unseen for too long—and to change the trajectory before maternal risk becomes truly irreversible.